Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aquinox
Biotech
IL-2 player Neoleukin gets a leg up in Aquinox merger
Through the merger, Neoleukin gets an on-ramp to public financing that will push a computationally designed IL-2 drug.
Amirah Al Idrus
Aug 6, 2019 9:18am
Chutes & Ladders—Gilead director joins Nimbus to lead discovery
Jul 13, 2018 8:30am
After phase 3 rout, Aquinox to cut staff by 53%
Jul 10, 2018 10:08am
Aquinox to halt inflammatory pain drug after phase 3 failure
Jun 27, 2018 10:12am
Astellas inks deal for phase 3 inflammatory pain drug
May 10, 2018 9:05am
